[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.124.106. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
April 10, 1972

Entero-Vioform for Preventing Travelers' Diarrhea

Author Affiliations

Center for Disease Control Atlanta

JAMA. 1972;220(2):273-274. doi:10.1001/jama.1972.03200020081018

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.

Abstract

Travelers' diarrhea can be an unpleasant complication of a business or vacation trip abroad. The prospect of succumbing to the "Aztec two-step" or "Delhi belly" causes more anxiety on the part of the prospective traveler than any other health-related aspect of his trip. Because means are available for preventing malaria, smallpox, typhoid, and other more serious threats to the traveler, his natural inclination is to take something he thinks will protect him from diarrhea. The drug most commonly used for this indication is iodochlorhydroxyquin (Entero-Vioform), and over the years it has become the travelers' vade mecum. In this issue of The Journal two letters (p 275) and a case report (p 243) raise the issues of the safety and efficacy of iodochlorhydroxyquin. With the vacation season approaching, physicians should be aware of the controversy concerning iodochlorhydroxyquin and the best methods to prevent travelers' diarrhea.

Diarrhea in travelers occurs most commonly

×